Recent Company News

• 12:13 PM ET May 22, 2026
  

  OpenAI prevails at trial, clearing way for IPO; attacks continue on proxy advisors for ESG practices in litigation themes (22-May)

• 12:17 PM ET May 21, 2026
  

  FDA recommends boxed warning be added to Adzynma (¥5180.0000, 0)

• 11:01 AM ET May 21, 2026
  

  StreetAccount ESG Press Digest

• 01:18 AM ET May 19, 2026
  

  StreetAccount Themes APAC Headlines (19-May)

• 09:27 PM ET May 18, 2026
  

  Takeda Pharmaceutical confirms jury verdict against Takeda in the Amitiza trial (¥5300.0000, +51)

• 02:34 PM ET May 18, 2026
  

  Takeda Pharmaceutical ordered to pay hundreds of millions in damages for delaying the generic version of Amitizia - Bloomberg (¥5249.0000, 0)

• 09:07 AM ET May 13, 2026
  

  Transcript Intelligence: Takeda Pharmaceutical Q4 Earnings Guidance

• 09:07 AM ET May 13, 2026
  

  Transcript Intelligence: Takeda Pharmaceutical Q4 Earnings Themes

• 09:07 AM ET May 13, 2026
  

  Transcript Intelligence: Takeda Pharmaceutical Q4 Earnings Q&A

• 03:00 AM ET May 13, 2026
  

  StreetAccount Metrics Recap - Takeda Pharmaceutical Q4 Earnings (¥5192.0000, 0)